Topics of Discussion:

Through expert interviews, discussions, and market analysis, DCAT Value Chain Insights provides need-to-know information to keep pace with a changing marketplace:

• Market Watch: Tracking the performance of the global pharmaceutical industry and leading market sectors.

• Industry Radar: Highlighting what needs to be on your radar: the key developments and trends in the pharmaceutical manufacturing value chain.

• Executive Insights: Leaders in Pharma provides strategies of leading executives from the companies making the news. DCAT Value Chain Insights Top 10 offers snapshots of significant pharma industry trends. Policy Watch provides interviews and analysis with leaders from the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on the major regulatory issues impacting manufacturing and the supply chain.

• Straight Talk From the Buy and Sell Side: Through case studies, industry roundtables, and reports, “Straight Talk” offers practical insight, lessons learned, and industry views on the issues most impactful to the pharmaceutical customer–supplier relationship.

Plus Top Industry News: To help ensure DCAT members never miss the most important stories impacting the global pharmaceutical manufacturing value chain, DCAT delivers each Friday, the week’s Top Industry News, a companion newsletter to DCAT Value Chain Insights that highlights the top news stories of the week.

SPECIAL DCAT WEEK 2019 COVERAGE

Special Preview Coverage

Special Report: Countdown to DCAT Week ’19: Featured in the February 20 and March 6 issues.

 

Special Post Coverage after DCAT Week

Special Report: DCAT Week ’19 Review:  Featured in the April 10 issue.

2019 DCAT Value Chain Insights Editorial Calendar

 

Issue Date	Topic
January 9	Market Watch: Pharma Industry Outlook
January 16	Industry Radar: The Year Ahead in Pharma Outsourcing
January 23	Executive Insights: Leaders in Pharma

Plus Top Industry News (delivered on Fridays): January 4, 11, 18, and 25

 

February 6	Market Watch: APIs: Small Molecules
February 13	Industry Radar: Drug Products: Parenteral Drugs
February 20	Special Report: Countdown to DCAT Week ’19

Top Industry News: February 1, 8, 15, and 22

 

March 6*

Special Report: Countdown to DCAT Week ’19

Top Industry News: March 1 and 8

*To accommodate our readers’ very busy schedules before, during, and post DCAT Week ‘19 (March 18-21), there will be no issues of DCAT Value Chain Insights and Top Industry News March 13 through April 5

 

April 10	Special Report: DCAT Week ’19 Review
April 24	Straight Talk: Biomanufacturing

Top Industry News: April 12 and 26

 

May 1	Market Watch: Blockbuster Watch
May 8	Industry Radar: Generics
May 15	Executive Insights: FDA/EMA Policy Watch

Top Industry News: May 3, 10, 17  and 31

 

June 5	Market Watch: Fine Chemicals
June 12	Industry Radar: What’s Trending in Pharma Outsourcing
June 19	Executive Insights: Leaders in Pharma
June 26	Straight Talk: Raw Materials Sourcing

Top Industry News: June 7, 14, 21, and 28

 

July 17	Executive Insights: Mid-Year Review: Top 10 Deals of 2019
July 24	Straight Talk: Evolving CDMO/CMO Business Models

 

Top Industry News: July 19 and 26

 

August 7	Market Watch: What’s New in Biologics
August 21	Executive Insights: Leaders in Pharma

Top Industry News: August 9, 16, 23 and 30

 

September 11	Industry Radar: CDMO/CMO Expansions
September 18	Executive Insights: Top 10 Manufacturing Trends
September 25	Straight Talk: API Sourcing

Top Industry News: September 6, 13, 20, and 27

 

October 2	Market Watch: High-Potency Manufacturing
October 16	Executive Insights: Leaders in Pharma
October 23	Straight Talk: Drug Product Development & Manufacturing

Top Industry News: October 4, 11, 18 and 25

 

November 13	Industry Radar: Biosimilars
November 20	Straight Talk: Single versus Dual Sourcing

Top Industry News: November 1, 8, 15, 22 and 29

 

December 4	Market Watch: The Year in Review
December 11	Executive Insights: Top 10 Pharma Trends: What’s on the Horizon for 2020

Top Industry News: December 6, 13 and 20